Clinical Trial Update: Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating low-dose capecitabine as adjuvant chemotherapy for elderly patients with stage II/III colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: West China Hospital | Conditions: Colorectal Neoplasms | Phase 3 | Status: UNKNOWN